---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-25-014818"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2025-10-09T23:59:59+00:00"
generated_at: "2026-05-17T04:11:55.959665+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro issues 361,743 shares on Series B Preferred conversion

## Summary
- Between Oct 1-8, 2025, 361,743 shares issued upon conversion of ~839.2 Series B Convertible Preferred shares.
- Shares issued under Section 4(a)(2) exemption from registration.
- As of Oct 8, 2025, total common shares outstanding: 3,801,604.
- Conversion increases outstanding share count by roughly 10.5% from prior level.

## SEC filing metadata
- accession: 0001214659-25-014818
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2025-10-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465925014818/0001214659-25-014818-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465925014818/o1082528k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-25-014818
- JSON: https://secwatch.observer/filing/0001214659-25-014818.json
- Plain text: https://secwatch.observer/filing/0001214659-25-014818.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.